New Gut Microbiome Research Targets Portal Hypertension Dr David Johnson explores recent data with urolithin A, a gut metabolite that’s shown early promise in studies with portal hypertension.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback